CEDAR KNOLLS, N.J., Feb. 11 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules using its eligen(R) technology, today announced that it will Web cast its presentation at the BIO CEO & Investor Conference on February 12, 2008 on its Web site. Listeners should go to the Investor Relations page of the Emisphere Web site at http://www.emisphere.com/ir.asp at 2:45 PM to hear the live presentation. Michael V. Novinski, President and Chief Executive Officer of Emisphere, will present for the company at 2:45 PM in the Lexington Suite of the Hotel. Gary Riley, BVSc, MVSc, Vice President, Nonclinical Development and Applied Biology, will co-present.
For more information on the BIO CEO & Investor Conference, including registration, hotel accommodations and an up-to-date program, please visit the conference Web site at http://ceo.bio.org/opencms/ceo/2008/index.jsp.
About Emisphere Technologies, Inc.
Emisphere Technologies, Inc. is a biopharmaceutical company that
focuses on a unique and improved delivery of therapeutic molecules using
its eligen(R) technology. These molecules and compounds could be currently
available or in development. Such molecules are usually delivered by
injection; in many cases, their benefits are limited due to poor
bioavailability, slow on-set of action or variable absorption. The
eligen(R) technology can be applied to the oral route of administration as
well other delivery pathways, such as buccal, rectal, inhalation,
intra-vaginal or transdermal. The web
|SOURCE Emisphere Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved